Mayur C. Yergeri

585 total citations
10 papers, 455 citations indexed

About

Mayur C. Yergeri is a scholar working on Molecular Biology, Organic Chemistry and Biomaterials. According to data from OpenAlex, Mayur C. Yergeri has authored 10 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Biomaterials. Recurrent topics in Mayur C. Yergeri's work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Mayur C. Yergeri is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Mayur C. Yergeri collaborates with scholars based in India, Poland and Netherlands. Mayur C. Yergeri's co-authors include Thirumala Govender, Rohit Srivastava, Clara Fernandes, Manikanta Murahari, Fikret Türkan, Kenan Buldurun, Nevin Turan, Ercan Bursal, Abdülmelik Aras and Naki Çolak and has published in prestigious journals such as Frontiers in Pharmacology, Current Pharmaceutical Design and BioMetals.

In The Last Decade

Mayur C. Yergeri

9 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayur C. Yergeri India 8 198 186 157 155 59 10 455
Seulki Lee South Korea 9 260 1.3× 193 1.0× 78 0.5× 185 1.2× 39 0.7× 13 556
Guangxuan Liu China 11 151 0.8× 160 0.9× 103 0.7× 186 1.2× 31 0.5× 29 507
Zeljko M. Prijovich Taiwan 16 258 1.3× 114 0.6× 91 0.6× 104 0.7× 56 0.9× 27 498
Guimin Xia China 12 231 1.2× 169 0.9× 66 0.4× 124 0.8× 93 1.6× 24 470
Amit Singh United States 7 308 1.6× 216 1.2× 80 0.5× 150 1.0× 42 0.7× 7 595
Guanru Wang China 10 183 0.9× 178 1.0× 66 0.4× 257 1.7× 50 0.8× 21 481
Disha Marwaha India 11 201 1.0× 138 0.7× 63 0.4× 141 0.9× 33 0.6× 18 427
Abraham H. Abouzeid United States 8 313 1.6× 399 2.1× 146 0.9× 266 1.7× 39 0.7× 9 680
Noor Alam India 13 225 1.1× 298 1.6× 140 0.9× 153 1.0× 34 0.6× 14 574
Yongkai Cao China 9 239 1.2× 194 1.0× 68 0.4× 254 1.6× 40 0.7× 21 589

Countries citing papers authored by Mayur C. Yergeri

Since Specialization
Citations

This map shows the geographic impact of Mayur C. Yergeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayur C. Yergeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayur C. Yergeri more than expected).

Fields of papers citing papers by Mayur C. Yergeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayur C. Yergeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayur C. Yergeri. The network helps show where Mayur C. Yergeri may publish in the future.

Co-authorship network of co-authors of Mayur C. Yergeri

This figure shows the co-authorship network connecting the top 25 collaborators of Mayur C. Yergeri. A scholar is included among the top collaborators of Mayur C. Yergeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayur C. Yergeri. Mayur C. Yergeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yadav, Tanuja, Mukesh Nandave, Vikas Dighe, et al.. (2024). Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study. Drug Development Research. 85(4).
3.
Wairkar, Sarika, et al.. (2020). Current Developments in Targeted Drug Delivery Systems for Glioma. Current Pharmaceutical Design. 26(32). 3973–3984. 14 indexed citations
4.
Kumar, Maushmi S., et al.. (2019). Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment. Current Pharmaceutical Design. 25(31). 3323–3338. 14 indexed citations
5.
Fernandes, Clara, et al.. (2018). Tumor Microenvironment Targeted Nanotherapy. Frontiers in Pharmacology. 9. 1230–1230. 113 indexed citations
6.
Martis, Elvis A. F., et al.. (2015). Drug–DNA Interaction Studies of Acridone-Based Derivatives. Nucleosides Nucleotides & Nucleic Acids. 34(5). 309–331. 19 indexed citations
7.
Yergeri, Mayur C., et al.. (2014). Nanodrug delivery in reversing multidrug resistance in cancer cells. Frontiers in Pharmacology. 5. 159–159. 215 indexed citations
8.
Murahari, Manikanta & Mayur C. Yergeri. (2014). Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer. 1(2). 127–148. 8 indexed citations
9.
Mangannavar, Chandrashekhar V., et al.. (2013). Synthesis and in vitro Cytotoxicity Studies of Certain Novel Heterocycles Derived from Bis 1, 2, 4-Triazoles and their DNA Damage Studies. Medicinal Chemistry. 9(8). 1063–1072. 1 indexed citations
10.
Murahari, Manikanta & Mayur C. Yergeri. (2013). Identification and Usage of Fluorescent Probes as Nanoparticle Contrast Agents in Detecting Cancer. Current Pharmaceutical Design. 19(25). 4622–4640. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026